These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3021401)

  • 1. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 2. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 6. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 11. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpesvirus hominis: from latency to carcinogenesis?
    Aurelian L
    Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpesvirus antigens as markers for cervical cancer.
    Gupta PK; Aurelian L; Frost JK; Carpenter JM; Klacsmann KT; Rosenshein NB; Tyrer HW
    Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S232-58. PubMed ID: 6273263
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
    Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
    Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic and biochemical characterization of individual polypeptides induced by herpes simplex virus types 1 and 2.
    Courtney RJ
    Adv Pathobiol; 1976; (5):87-103. PubMed ID: 220860
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.